by ltsiwpadmin | Jul 27, 2017 | News
by Scott Harris, Contributing Writer, MedPage Today July 27, 2017 This article is a collaboration between MedPage Today® and: Medpage Today “Despite … limitations, our study provides evidence that the pathogenesis of subclinical heart failure may relate to...
by ltsiwpadmin | Jul 25, 2017 | News
Date: July 25, 2017 Source: Universität Mainz SUMMARY Non-alcoholic fatty liver disease (NAFLD) is one of the most frequent liver diseases worldwide. The underlying causes involve obesity and decreased physical activity leading to accompanying metabolic and...
by ltsiwpadmin | Jul 20, 2017 | Overview & Epidemiology, Publications
Abstract The cleavage and secretion of pro-inflammatory cytokines IL-1β and IL-18 is regulated by NLRP3 (NACHT, LRR, and PYD domain-containing protein 3) inflammasome activation. Kupffer cells (KCs) are implicated in the pathogenesis of various liver diseases, such as...
by ltsiwpadmin | Jul 18, 2017 | News
Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Non-Alcoholic Steatohepatitis (NASH) – Pipeline Review, H2 2018, provides an overview of the Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) pipeline landscape....
by ltsiwpadmin | Jul 6, 2017 | News
Lydia Ramsey July 6, 2017 Millions of people are living with a “silent” disease they’ve likely never heard of. NASH, short for nonalcoholic steatohepatitis, is a type of liver disease in which liver fat builds up in people. NASH has become more...
Recent Comments